Stay updated with breaking news from Nasdaq lyra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ENLIGHTEN 1 trial did not meet its primary endpoint Company plans to evaluate full dataset and path forward WATERTOWN, Mass., May 06, 2024 (GLOBE. ....
HC Wainwright reiterated their buy rating on shares of Lyra Therapeutics (NASDAQ:LYRA – Free Report) in a research report report published on Wednesday, Benzinga reports. HC Wainwright currently has a $12.00 price target on the stock. A number of other research analysts have also commented on LYRA. Bank of America lowered their price target on […] ....
Lyra Therapeutics (NASDAQ:LYRA – Free Report) had its price target trimmed by Bank of America from $12.00 to $11.00 in a research report released on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock. LYRA has been the subject of several other reports. HC Wainwright reiterated a buy rating and issued […] ....
Lyra Therapeutics, Inc. (NASDAQ:LYRA – Get Free Report) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 421,100 shares, a growth of 661.5% from the August 31st total of 55,300 shares. Based on an average trading volume of 348,200 shares, the days-to-cover ratio […] ....
HC Wainwright assumed coverage on shares of Lyra Therapeutics (NASDAQ:LYRA – Free Report) in a research report released on Thursday, MarketBeat reports. The brokerage issued a buy rating and a $12.00 price target on the stock. Lyra Therapeutics Stock Up 0.3 % Shares of LYRA stock opened at $3.49 on Thursday. The business has a […] ....